QFY18 Results: Dr Reddy's Laboratories Ltd

DSIJ Intelligence / 27 Jul 2017

QFY18 Results: Dr Reddy's Laboratories Ltd

The company's total sales for Q4FY17 came in at Rs 3248.9 crore, which represents a 7.13 per cent sequential decline and 1.98 per cent YoY increase.

Dr. Reddy's Laboratories Ltd. reported its results for the quarter ended June 30, 2017 today.  

The company's total sales for Q4FY17 came in at Rs 3248.9 crore, which represents a 7.13 per cent sequential decline and 1.98 per cent YoY increase.

Its operating loss (EBIT) for the quarter amounted to Rs. 19.6 crore
 
The company reported PAT of Rs 56.8 crore, which represents a sequential QoQ decline of 82.65 per cent and a YoY decline of 61.15 per cent.

The company's stock opened for trading at Rs 2,719 on the BSE, fell 4.15 per cent after the results were declared and closed around Rs 2,600..
 
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The company operates in three segments: global generics, pharmaceutical services and active ingredients (PSAI), and proprietary products

If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.